Current Problems in Cardiology最新文献

{"title":"Guidelines for Authors","authors":"","doi":"10.1016/S0146-2806(25)00116-1","DOIUrl":"10.1016/S0146-2806(25)00116-1","url":null,"abstract":"","PeriodicalId":51006,"journal":{"name":"Current Problems in Cardiology","volume":"50 7","pages":"Article 103094"},"PeriodicalIF":3.0,"publicationDate":"2025-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144167406","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Information for Readers","authors":"","doi":"10.1016/S0146-2806(25)00110-0","DOIUrl":"10.1016/S0146-2806(25)00110-0","url":null,"abstract":"","PeriodicalId":51006,"journal":{"name":"Current Problems in Cardiology","volume":"50 7","pages":"Article 103088"},"PeriodicalIF":3.0,"publicationDate":"2025-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144167408","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Title Page","authors":"","doi":"10.1016/S0146-2806(25)00109-4","DOIUrl":"10.1016/S0146-2806(25)00109-4","url":null,"abstract":"","PeriodicalId":51006,"journal":{"name":"Current Problems in Cardiology","volume":"50 7","pages":"Article 103087"},"PeriodicalIF":3.0,"publicationDate":"2025-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144167404","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Editor’s Message","authors":"","doi":"10.1016/S0146-2806(25)00115-X","DOIUrl":"10.1016/S0146-2806(25)00115-X","url":null,"abstract":"","PeriodicalId":51006,"journal":{"name":"Current Problems in Cardiology","volume":"50 7","pages":"Article 103093"},"PeriodicalIF":3.0,"publicationDate":"2025-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144167403","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Erratum to “The effect of individualized nutrition training of children with congenital heart disease (CHD) on their growth and development a randomized controlled trial” [Current Problems in Cardiology 49(2024 102567]","authors":"Emel Yuruk Phd, Senay Cetinkaya Phd","doi":"10.1016/j.cpcardiol.2025.103078","DOIUrl":"10.1016/j.cpcardiol.2025.103078","url":null,"abstract":"","PeriodicalId":51006,"journal":{"name":"Current Problems in Cardiology","volume":"50 8","pages":"Article 103078"},"PeriodicalIF":3.0,"publicationDate":"2025-05-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144154701","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Symphony of crossfire: Aneurysm, dual vessel occlusion, and lymphoma’s hypercoagulable crescendo a case report","authors":"Said Al-Najjar ,&nbsp;Noor Abu Hantash ,&nbsp;Dana Bader","doi":"10.1016/j.cpcardiol.2025.103079","DOIUrl":"10.1016/j.cpcardiol.2025.103079","url":null,"abstract":"<div><div>Occult asymptomatic myocardial infarction in patients with malignancy (lymphoma), advanced age, and multiple comorbidities may present atypically, complicating the diagnosis of presumed recurrent infarction. We present a highly complex case of a 66-year-old male with lymphoma and multiple comorbidities who collapsed with diffuse ST-segment elevation on electrocardiography (ECG). The diagnostic challenge required concurrent percutaneous coronary intervention (PCI) and echocardiography to identify the thrombotic occlusions in two coronary vessels. Empirical placement of stents in the right coronary artery and left circumflex artery resolved the acute occlusions, while retrograde imaging revealed a previously undiagnosed anteroapical left ventricular aneurysm. This case underscores the importance of integrating multimodal imaging in oncological patients with atypical cardiovascular presentations.</div></div>","PeriodicalId":51006,"journal":{"name":"Current Problems in Cardiology","volume":"50 8","pages":"Article 103079"},"PeriodicalIF":3.0,"publicationDate":"2025-05-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144175623","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Arrhythmic mitral valve prolapse: In which patients should primary prevention of sudden cardiac death be considered and how should it be implemented?","authors":"Juan M. Iroulart,&nbsp;Rocío Blanco,&nbsp;Ana L. Miceli,&nbsp;Rodrigo P. Bagnati,&nbsp;Maria C. Bartolomé Roca,&nbsp;Mariano G. Bergier,&nbsp;Juan G. Krauss,&nbsp;Florencia Parcerisa,&nbsp;Pablo F. Oberti,&nbsp;Mariano L. Falconi,&nbsp;Rodolfo Pizarro","doi":"10.1016/j.cpcardiol.2025.103083","DOIUrl":"10.1016/j.cpcardiol.2025.103083","url":null,"abstract":"<div><div>Mitral valve prolapse (MVP) affects 2–3 % of the population and is generally benign. However, a subgroup presents severe complications such as ventricular arrhythmias and sudden cardiac death (SCD). Arrhythmogenic mitral valve prolapse (AMVP) combines MVP with frequent or complex ventricular arrhythmias in the absence of other causes. Although SCD in AMVP patients is rare (0.2–0.4 %, annual), it exceeds the general population rate and is associated with specific high arrhythmic risk features, such as mitral annular disjunction (MAD), bileaflet prolapse, Pickelhaube sign, abnormal T waves on the electrocardiogram, and rapid non-sustained ventricular tachycardia. Primary prevention is crucial but challenged by the lack of standardized guidelines. AMVP requires a multidisciplinary and cost-effective evaluation to stratify risk and prevent SCD in a predominantly young and healthy population.</div><div>The objective of this review is to describe the variables with the highest arrhythmogenic risk in patients with MVP and the possible primary prevention strategies for sudden cardiac death.</div></div>","PeriodicalId":51006,"journal":{"name":"Current Problems in Cardiology","volume":"50 8","pages":"Article 103083"},"PeriodicalIF":3.0,"publicationDate":"2025-05-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144138225","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Assessment of cardiac masses by magnetic resonance imaging: prognostic value and agreement with histopathology","authors":"Sebastián Tonso ,&nbsp;Santiago del Castillo ,&nbsp;Fernando Garagoli ,&nbsp;Eugenia Pomeraantz ,&nbsp;Rocio Blanco ,&nbsp;Ezequiel Guzzetti ,&nbsp;Emiliano Rossi ,&nbsp;Diego Pérez de Arenaza ,&nbsp;Mariano Falconi ,&nbsp;Rodolfo Pizarro","doi":"10.1016/j.cpcardiol.2025.103084","DOIUrl":"10.1016/j.cpcardiol.2025.103084","url":null,"abstract":"<div><h3>Background</h3><div>Cardiovascular magnetic resonance (CMR) is a highly valuable tool for evaluating cardiac masses (CM). However, data on its ability to predict patient outcomes remain limited. Therefore, our objective was to assess the accuracy of CMR in determining malignancy, its association with mortality, and its agreement with histopathological analysis.</div></div><div><h3>Methods</h3><div>This was an observational, retrospective study. We examined patients who underwent CMR due to suspected CM from January 2004 to June 2023 at an university hospital. Patients with suspected infarction-related thrombosis were excluded. Data were collected from electronic medical records. Images were reanalyzed in a blinded manner by two cardiac imaging specialists, documenting predefined imaging characteristics to classify masses as malignant or non-malignant (including cysts, thrombi, and normal variants), leading to a presumptive diagnosis. Mortality rates across groups were compared using survival analysis and Cox regression. In cases with histological confirmation, agreement between the presumptive CMR diagnosis and the final histological diagnosis was evaluated using the Cohen’s Kappa coefficient.</div></div><div><h3>Results</h3><div>We identified 75 patients with suspected CM, of which 24 (32 %) were classified as malignant and 51 (68 %) as non-malignant. Imaging variables most strongly associated with malignancy included the presence of multiple masses, involvement of multiple chambers, signs of infiltration, pericardial effusion, perfusion abnormalities, and late gadolinium enhancement. In contrast, mass mobility was associated with a non-malignant diagnosis.</div><div>The median follow-up was 30 months [IQR 4-67.5]. Malignant masses identified by CMR were associated with higher mortality: (HR: 3.72; 95 % CI: 1.8–7.72, <em>p</em> &lt; 0.001). Histopathological studies were performed in 34 patients (45 %) and compared with the presumptive etiological diagnosis obtained by CMR. The level of agreement was excellent for malignancy (<em>k</em> = 0.88, <em>p</em> &lt; 0.001) and good for etiological diagnosis (<em>k</em> = 0.63, <em>p</em> &lt; 0.001).</div></div><div><h3>Conclusions</h3><div>Malignancy of a CM, as determined by CMR, was associated with higher mortality. There was good agreement between the presumptive diagnosis by CMR and the histopathological findings.</div></div>","PeriodicalId":51006,"journal":{"name":"Current Problems in Cardiology","volume":"50 8","pages":"Article 103084"},"PeriodicalIF":3.0,"publicationDate":"2025-05-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144152845","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Machine learning algorithms for heart disease diagnosis: A systematic review","authors":"Yian Mao ,&nbsp;Bahiru Legesse Jimma ,&nbsp;Tefera Belsty Mihretie","doi":"10.1016/j.cpcardiol.2025.103082","DOIUrl":"10.1016/j.cpcardiol.2025.103082","url":null,"abstract":"<div><h3>Background</h3><div>The heart is a vital organ that pumps blood throughout the body. Its proper functioning is crucial for maintaining overall health, and any malfunction can significantly impact other bodily systems. Recently, machine learning has emerged as a valuable tool in cardiology, enhancing the prediction and diagnosis of heart diseases. By analyzing clinical data, these algorithms reveal patterns that traditional methods might miss, aiding in early detection and personalized treatment. This study aimed to evaluate the most widely used and accurate supervised machine-learning algorithms for predicting and diagnosing heart disease.</div></div><div><h3>Methods</h3><div>A systematic analysis was conducted using research articles obtained from six reputable academic databases: Scopus, PubMed, ScienceDirect, Dimensions, ProQuest, and IEEE. The review covers the years from 2013 to 2024. The focus was on the application of various supervised machine-learning algorithms for diagnosing heart disease.</div></div><div><h3>Result</h3><div>The study identified twenty-four relevant studies that examined the use of supervised machine learning algorithms for diagnosing and predicting heart disease. Among these, five algorithms were prominent: Decision Trees, Logistic Regression, Naive Bayes, Random Forests, and Artificial Neural Networks. Decision Trees were found to be the most commonly applied and best-performing algorithm, followed by Logistic Regression and Naive Bayes. However, Artificial Neural Networks and Random Forests received less attention despite their potential for high accuracy in certain contexts.</div></div><div><h3>Conclusion</h3><div>The research findings highlight important trends in heart disease prediction models using supervised machine learning. By examining these trends, researchers can identify algorithms that improve forecasting accuracy, guiding future research objectives and advancing the effectiveness of heart disease diagnosis.</div></div>","PeriodicalId":51006,"journal":{"name":"Current Problems in Cardiology","volume":"50 8","pages":"Article 103082"},"PeriodicalIF":3.0,"publicationDate":"2025-05-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144152846","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Safety and effectiveness after atrial shunt device in patients with heart failure:A systematic review and Meta-Analysis","authors":"Lihua Gao,&nbsp;Zhenze Yu,&nbsp;Pengfei Wang,&nbsp;Zihan Zhao","doi":"10.1016/j.cpcardiol.2025.103080","DOIUrl":"10.1016/j.cpcardiol.2025.103080","url":null,"abstract":"<div><h3>Background</h3><div>Limited data are available regarding the atrial shunt device (ASD), making it challenging to provide definitive recommendations for patients with heart failure (HF). We conducted a meta-regression analysis to identify individuals who may derive greater benefit from this device.</div></div><div><h3>Methods</h3><div>We conducted a search across PubMed, EMBASE, and Cochrane databases, including 8 studies for meta-analysis. Estimated endpoints were derived using random-effects proportional meta-analysis. Additionally, meta-regression analysis was performed to elucidate the potential impact of key covariates on these endpoints.</div></div><div><h3>Results</h3><div>A total of 522 patients were included. The pooled analysis revealed an estimated mortality rate of 1.9 % for patients who underwent ASD. Additionally, the proportion of patients who remained in NYHA III to IV was reduced to 22.5 %. Furthermore, there was an improvement of 35.1 meters in the 6-minute walk distance (6MWD) and a 16.2-point improvement in the KCCQ score. Meta-regression analysis indicated that NYHA III to IV status was found to be directly proportional to age (β= 2.799), hypertension (β= 0.782), diabetes (β= 0.951), and atrial fibrillation (β= 0.778). Hypertension and a high level of left ventricular ejection fraction (LVEF) were associated with less improvement in 6MWD and KCCQ score, whereas a higher NT-proBNP level was associated with better improvement in 6MWD and KCCQ score.</div></div><div><h3>Conclusions</h3><div>ASD emerges as a safe choice for HF patients aiming to alleviate symptoms. Specifically, individuals with reduced EF or elevated NT-proBNP levels, and without concomitant hypertension, diabetes, or atrial fibrillation, appear to achieve more substantial symptom relief.</div></div>","PeriodicalId":51006,"journal":{"name":"Current Problems in Cardiology","volume":"50 8","pages":"Article 103080"},"PeriodicalIF":3.0,"publicationDate":"2025-05-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144138224","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}